SAR研究和setmelanotide的协同优化产生了一种强效,选择性和可溶性MC4R激活剂

Chen Guo1, Tao Luo2, Yuanzhen Dong3

  • 1School of Pharmaceutical Sciences, Shanghai Jiao Tong University, 200240 Shanghai, China; National Key Laboratory of Lead Druggability Research, 201203 Shanghai, China.

Bioorganic chemistry
|December 16, 2025
PubMed
概括

研究人员开发了一种新的,SC19,以改善肥胖治疗中的setmelanotide. SC19显示出增强的溶解性和选择性,提供潜在的治疗益处,副作用较少.